[Antithyroid drug-induced agranulocytosis. A rare but dreaded condition].
Lehtihet
Mikael
M
Sektionen för endokrinologi och diabetologi, Södersjukhuset, Stockholm. mikael.lehtihet@sodersjukhuset.se
Zedenius
Jan
J
Helldén
Anders
A
Axelsson
Rimma
R
Calissendorff
Jan
J
D000328:Adult; D000380:Agranulocytosis / Q000139:chemically induced* / Q000188:drug therapy / Q000382:microbiology; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D013956:Antithyroid Agents / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D000069585:Filgrastim; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D006111:Graves Disease / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery; D006801:Humans; D007037:Hypothyroidism / Q000188:drug therapy* / Q000532:radiotherapy / Q000601:surgery; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D008713:Methimazole / Q000009:adverse effects; D011441:Propylthiouracil / Q000008:administration & dosage / Q000009:adverse effects; D011994:Recombinant Proteins; D013965:Thyroidectomy
D000900:Anti-Bacterial Agents; D013956:Antithyroid Agents; D007457:Iodine Radioisotopes; D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D008713:Methimazole; D011441:Propylthiouracil; D000069585:Filgrastim